does semaglutide increase sex drive in women and metformin improve menstrual cyclicity overweight/obese with polycystic ovary syndrome: a randomized trial Ozempic, Libido & Erectile Dysfunction:

As always, any treatment decisions should be taken together with your doctor

While tirzepatide is currently approved for weight management and type 2 diabetes, the migraine data opens a conversation about potential off-label applications

A second factor in plateaus is behavioral adaptation

Although both drug classes could theoretically offer neuroprotective benefits based on their mechanisms of action, RCTs have provided mixed or inconclusive results

Its important for individuals to understand that weight loss should be gradual to ensure its sustainable

Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition